Machine learning use in healthcare still limited to proof-of-concept studies

Machine learning (ML) technology has gained popularity in recent years, but its use in healthcare remains largely limited to proof-of-concept academic studies, according to a new study published in Artificial Intelligence in Medicine.

“AI has the potential to profoundly transform medical practice by aiding physicians’ interpretation of complex and diverse data types,” wrote lead author David Ben-Israel, department of clinical neurosciences at the University of Calgary, and colleagues. “If AI successfully translates into a busy clinician’s practice, it stands to improve the performance of diagnosis, prognostication and management decisions.”

So will ML translate into a busy practice? Ben-Israel and colleagues aimed to track the progression of ML implementation in modern health systems, searching through original studies on the topic published between Jan. 1, 2000, and May 1, 2018.

All studies were published in English and specifically examined the use of ML to improve patient care. Editorials, book chapters, white papers, case reports, conference abstracts and other similar documents were all excluded.

Overall, 386 publications were identified that involved the implementation of a ML strategy “to address a specific clinical problem.” Ninety-eight percent of those studies were retrospective. The authors wrote that ML stands to be a true game-changer for healthcare, but certain limitations remain that must be addressed.

“Access to real-time clinical data, data security, physician approval of ‘black box’ generated results, and performance evaluation are important aspects of implementing a ML based data strategy,” Ben-Israel et al. concluded. “Not all clinical problems will be amenable to an AI based data strategy. The careful definition of a clinical problem and the gathering of requisite data for analysis are important first steps in determining if computer science methods within medicine may advance what human intelligence has been able to accomplish.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”